A COMPARISON OF INTERFERON ALFA-2A AND PODOPHYLLIN IN THE TREATMENT OF PRIMARY CONDYLOMATA ACUMINATA

被引:0
|
作者
MAW, RD
DINSMORE, W
HORNER, T
LAWTHER, H
RINNE, E
LASSUS, A
PAAVONEN, J
AHO, M
NIEMINEN, P
VESTERINEN, E
TUIMALA, RJ
JUUAKKA, T
SAASTAMOINEN, J
SYRJANEN, SM
SYRJANEN, KJ
WALKER, M
RYFF, JC
SMITH, C
BUDDE, M
BLACKBURN, N
ELLMEN, J
WAHL, M
机构
[1] UNIV HELSINKI,CENT HOSP,DEPT OBSTET & GYNAECOL,SF-00290 HELSINKI 29,FINLAND
[2] HELSINKI RES CTR,HELSINKI,FINLAND
[3] RN LAAKARIKESKUS TAMPERE,TAMPERE,FINLAND
[4] LAAKARIKESKUS SYYNI,KUOPIO,FINLAND
[5] UNIV KUOPIO,DEPT PATHOL,KUOPIO,FINLAND
[6] ROCHE BASEL,BASEL,SWITZERLAND
[7] ROCHE PROD LTD,WELWYN GARDEN CIT AL7 3AY,HERTS,ENGLAND
[8] ROCHE OY,ESPOO,FINLAND
[9] CLIN RES & COMMUN,BASEL,SWITZERLAND
来源
GENITOURINARY MEDICINE | 1991年 / 67卷 / 05期
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives - to compare the response to treatment and recurrence rate of condylomata accuminata using subcutaneous injection of interferon alfa 2a 1.5 million units three times weekly for four weeks, or podophyllin resin 25% applied to lesions twice weekly for up to six weeks. Design - Randomised open study. Setting - Multicentre European study in genitourinary medicine, dermatovenereology, and gynaecology departments. Patients - 87 males and 67 females with condylomata acuminata for less than six months and no history of previous treatment. Main outcome measures - Complete clearance of lesions and evidence of recurrence at three months and nine months after treatment commenced. Results - A complete response was achieved at three months in 15 of 64 (23%) in the interferon treated group, and 31 of 69 (45%) in the podophyllin treated group (p = 0.003). At nine months 10 of 13 patients in the interferon group and 22 of 30 patients in the podophyllin group remained completely clear of lesions. Conclusions - At the dose regimen used interferon alfa 2a monotherapy was not as effective a therapy as the standard therapy of podophyllin 25% application.
引用
收藏
页码:394 / 399
页数:6
相关论文
共 50 条
  • [31] HUMAN-LYMPHOBLASTOID INTERFERON (WELLFERON) IN PRIMARY THERAPY OF 2 CHILDREN WITH CONDYLOMATA ACUMINATA
    TROFATTER, KF
    ENGLISH, PC
    HUGHES, CE
    GALL, SA
    OBSTETRICS AND GYNECOLOGY, 1986, 67 (01): : 137 - 140
  • [32] Recombinant human interferon-beta in the treatment of condylomata acuminata
    Dinsmore, W
    Jordan, J
    OMahony, C
    Harris, JRW
    McMillan, A
    Radcliffe, KW
    Engrand, P
    Jackson, BW
    Galazka, AR
    ABdulAhad, AK
    Illingworth, JM
    INTERNATIONAL JOURNAL OF STD & AIDS, 1997, 8 (10) : 622 - 628
  • [33] SYSTEMIC INTERFERON-ALPHA TREATMENT OF HUMAN CONDYLOMATA ACUMINATA
    EINHORN, N
    LING, P
    STRANDER, H
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1983, 62 (03) : 285 - 287
  • [34] Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a
    Anadolu, R
    Oskay, T
    Erdem, C
    Boyvat, A
    Terzi, E
    Gürgey, E
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 45 (02) : 296 - 299
  • [35] CAUTION IN REGARD TO TREATMENT OF HEMANGIOMAS WITH INTERFERON ALFA-2A - REPLY
    EZEKOWITZ, RAB
    MULLIKEN, JB
    FOLKMAN, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (18): : 1321 - 1322
  • [36] TREATMENT OF CHILDHOOD ANGIOMATOUS DISEASES WITH RECOMBINANT INTERFERON ALFA-2A
    WHITE, CW
    WOLF, SJ
    KORONES, DN
    SONDHEIMER, HM
    TOSI, MF
    YU, A
    JOURNAL OF PEDIATRICS, 1991, 118 (01): : 59 - 66
  • [37] REGRESSION OF A VENOUS MALFORMATION DURING TREATMENT WITH INTERFERON ALFA-2A
    HORD, D
    GREER, JP
    BLOOD, 1994, 84 (10) : A677 - A677
  • [38] TREATMENT OF MULTIPLE-MYELOMA WITH RECOMBINANT INTERFERON ALFA-2A
    OHNO, R
    KIMURA, K
    CANCER, 1986, 57 (08) : 1685 - 1688
  • [39] Interferon alfa-2a for melanoma metastases
    Kirkwood, JM
    Ibrahim, JG
    Sondak, VK
    Ernstoff, MS
    Ross, M
    LANCET, 2002, 359 (9310): : 978 - 979
  • [40] LYMPHOMATOID PAPULOSIS - TREATMENT WITH RECOMBINANT INTERFERON ALFA-2A AND ETRETINATE
    WYSS, M
    DUMMER, R
    DOMMANN, SN
    JOLLERJEMELKA, HI
    DOURSZIMMERMANN, MT
    GILLIET, F
    BURG, G
    DERMATOLOGY, 1995, 190 (04) : 288 - 291